Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Tech Journal.
Press releases published on August 18, 2025
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Reports Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 18, 2025
NRx Drug Development Grant of expanded Fast Track Designation for NRX-100 from the FDA for all indications and types of depression and related disorders based on its potential to satisfy an unmet medical need. Represents an approximately 10-fold expansion …
Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases
GlobeNewswire
·
August 18, 2025
· Collaboration strengthens Boehringer’s pipeline in Eye Health. · Many patients with diabetic retinopathy (DR) continue to experience vision loss or treatment fatigue, underscoring an unmet need. · Melanocortin receptor agonists offer …
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority
GlobeNewswire
·
August 18, 2025
In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, cardiovascular events, and total health care costs. Findings …
Global Clinical Decision Support Systems Market to Reach USD 3.89 Billion by 2030 | MarketsandMarkets™
GlobeNewswire
·
August 18, 2025
Delray Beach, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Accelerating adoption of healthcare IT, rising focus on patient safety, and government-backed digital health initiatives reshape global care delivery The global clinical decision support systems (CDSS) …
OncoC4 Strengthens Leadership Team with Appointment of Shiniu Wei as Chief Financial Officer
GlobeNewswire
·
August 18, 2025
ROCKVILLE, Md., Aug. 18, 2025 (GLOBE NEWSWIRE) -- OncoC4, Inc., a late-stage biopharmaceutical company developing novel medicines for cancer today announced the appointment of Shiniu Wei as Chief Financial Officer (CFO). Mr. Wei joins OncoC4 with nearly 20 …
Aditude Appoints Anthony Gonsalves as First Chief Revenue Officer
GlobeNewswire
·
August 18, 2025
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Aditude, a leading technology company, today announced the appointment of Anthony Gonsalves as its first Chief Revenue Officer (CRO). Gonsalves joins Aditude from JWP Connatix, where he served as Senior Vice …
Nuvini Group Unveils New Leadership Incentive Plan, Underscoring Commitment to Shareholders
GlobeNewswire
·
August 18, 2025
~ Strengthens Leadership Incentives and Alignment Around Long-Term Growth Objectives and Disciplined Capital Allocation ~ NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading technology …
Legend Biotech Appoints Carlos Santos as Chief Financial Officer
GlobeNewswire
·
August 18, 2025
SOMERSET, N.J., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Carlos Santos as the Company’s Chief Financial Officer, effective immediately. …
LIXTE Biotechnology Holdings Provides Corporate Update
GlobeNewswire
·
August 18, 2025
-Completes Two Financings, Raising $6.5 Million- -Regains Compliance for Continued Listing on Nasdaq- -Announces Management Changes; Adds Two New Board Members- -Re-Establishes Scientific Advisory Committee- -Reports on New Findings Published in Scientific …
Pelthos Therapeutics Reports Second Quarter 2025 Financial Results for Legacy Operations and Provides Business Update
GlobeNewswire
·
August 18, 2025
Files Quarterly Report on Form 10-Q detailing financial results for legacy operations for the three and six months ended June 30, 2025 Strong physician response following successful launch of ZELSUVMI™ (berdazimer) topical gel 10.3%, the first and only FDA …
Opus Genetics Announces FDA Clearance of IND Application for Gene Therapy Candidate OPGx-BEST1
GlobeNewswire
·
August 18, 2025
– Phase 1/2 trial expected to initiate in 2H 2025 in patients with BEST1 inherited retinal disease RESEARCH TRIANGLE PARK, N.C., Aug. 18, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene …
NewAmsterdam Announces Acceptance of Marketing Authorization Applications for Review by European Medicine Agency for Obicetrapib
GlobeNewswire
·
August 18, 2025
-- Filings both for the obicetrapib monotherapy and obicetrapib plus ezetimibe fixed-dose combination submitted to EMA by our partner, Menarini, for treatment of adults with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed …
Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt
GlobeNewswire
·
August 18, 2025
Retired all principal and accrued interest owed its two senior secured lenders, Resorts World Inc. Pte. Ltd., or RWI, and C.V. Starr and Co., Inc., eliminating all senior secured debt from its balance sheet. Entered into an Asset Purchase Agreement with …
Treatment.com AI Inc. to Rebrand as Rocket Doctor AI Inc., Aligning Business with Evolving Product Portfolio and Market Strategy
GlobeNewswire
·
August 18, 2025
New name to take effect and begin trading on the Canadian Securities Exchange under the new ticker AIDR effective August 21, 2025 Rebrand unites the company’s proprietary Global Library of Medicine (GLM) with Rocket Doctor Inc’s leading digital health …
Rezolve Ai Celebrates One Year Anniversary of Nasdaq Listing with Explosive Growth, $70M+ ARR, and Global Expansion
GlobeNewswire
·
August 18, 2025
NEW YORK, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the company reinventing retail through real-time AI-driven consumer engagement, today celebrates a game-changing first year as a public company capping 12 months of growth, major …
Applied Digital to Break Ground on $3 Billion Polaris Forge 2 Campus in September 2025, Expanding North Dakota’s Role as a National AI Infrastructure Leader
GlobeNewswire
·
August 18, 2025
DALLAS, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD) announced today it plans to break ground in September 2025 on Polaris Forge 2, a $3 billion, 280-megawatt (MW) AI Factory near Harwood, North Dakota. Designed with the …
Enlivex Announces Positive Topline Data From Multi-Country, Randomized, Controlled, Phase I/II Trial Evaluating Allocetra in Patients With Moderate-To-Severe Knee Osteoarthritis
GlobeNewswire
·
August 18, 2025
ENX-CL-05-001 Trial: 3-months topline data - In the overall modified intention-to-treat (mITT) population, improvements across all efficacy and secondary endpoints, including 24% reduction in knee pain and 26% improvement in knee function, were observed …
Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
GlobeNewswire
·
August 18, 2025
-- Achieved Primary Endpoint with 30mg Dose of RE104 Demonstrating 23.0-Point Reduction from Baseline in Montgomery-Åsberg Depression Rating Scale (MADRS) Score on Day 7, a 5.8-Point Greater Reduction Than Patients Treated with 1.5mg Dose (p=0.0094) -- -- …
Plus Therapeutics Presents Positive ReSPECT-LM Clinical Trial Results of REYOBIQ™ in Leptomeningeal Metastases
GlobeNewswire
·
August 18, 2025
REYOBIQ produced a clinical benefit rate of over 75% in 3 clinically relevant outcome measures RNA sequencing and circulating tumor cell reduction consistent with tumor cell death No dose limiting toxicities were observed with an overall favorable safety …
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future Pak
GlobeNewswire
·
August 18, 2025
Shareholders stand to receive a significant and attractive cash premium, as the purchase price of US$3.01, with a contingent value right for potential additional aggregate payments of up to US$1.19 per share, represents a compelling premium of 216% to the …